This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Agilent (A) Up 6.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A), Visiopharm Unite for Supply of Pathology Solutions
by Zacks Equity Research
Agilent (A) signs an agreement with Visiopharm to globally distribute their pathology solutions.
Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (A) Outperforming Other Computer and Technology Stocks This Year?
Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Agilent (A) Boosts PD-L1 IHC 22C3 pharmDX Assay Use in Europe
by Zacks Equity Research
Agilent Technologies (A) boosts presence in the companion diagnostics market by expanding the use of PD-L1 IHC 22C3 pharmDx assay for esophageal cancer treatment in Europe.
Agilent (A) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Agilent's (A) fiscal third-quarter results benefit from strength across all geographical regions, business groups and end-market momentum.
Agilent Technologies (A) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 11.11% and 3.67%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Ahead of Keysight's (KEYS) Q3 Earnings Release
by Zacks Equity Research
Keysight's (KEYS) Q3 performance is likely to gain from higher demand for its solutions in semiconductor, automotive and aerospace & defense verticals.
What to Expect Ahead of Cisco's (CSCO) Q4 Earnings Release?
by Zacks Equity Research
Cisco's (CSCO) Q4 performance is likely to reflect gains from growing clout of security solutions, Webex and solid Catalyst 9000K adoption.
Agilent (A) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Agilent's (A) fiscal third-quarter results are likely to reflect strength across its segments and product portfolio.
Why Agilent Technologies (A) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Jack Henry (JKHY) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Jack Henry's (JKHY) fourth-quarter fiscal 2021 results are likely to reflect strength across Payments and Complementary segments despite the coronavirus woes.
Sea Limited (SE) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Sea Limited's (SE) second-quarter results are likely to reflect a strong momentum in digital entertainment and e-commerce business despite the coronavirus chaos.
Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Alcon (ALC) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Continued strength in the Surgical segment and new launches under Vision Care segment are likely to have driven growth in the second quarter for Alcon (ALC).
Wix.com (WIX) Q2 Loss In Line With Estimates, Revenues Up Y/Y
by Zacks Equity Research
Wix.com's (WIX) Q2 results benefit from momentum in Creative Subscriptions and Business Solutions revenues.
Should You Buy Agilent Technologies (A) Ahead of Earnings?
by Aditi Saraogi
Agilent Technologies (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Amcor (AMCR) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Amcor's (AMCR) fourth-quarter results likely to highlight benefits from strong demand in end markets and synergies from the Bemis acquisition. Higher input costs might have played spoilsport.
Upstart Holdings (UPST) Q2 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Upstart's (UPST) second quarter of 2021 results reflect benefits from an expanding bank partner.
Vishay (VSH) Q2 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Vishay's (VSH) second-quarter results benefit from strong momentum across its product lines.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Scientific Games (SGMS) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Scientific Games' (SGMS) second-quarter 2021 results reflect strong growth in Gaming, Lottery and Digital businesses.
Baidu (BIDU) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Baidu's (BIDU) second-quarter results are likely to reflect gains from the AI business, autonomous driving efforts and the iQIYI segment.
Tencent (TCEHY) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tencent's (TCEHY) Q2 results are likely to reflect user growth, driven by gaming portfolio strength and growth in digital content revenues.